ANI Pharmaceuticals was counseled by Davis Polk & Wardwell in a debt offering valued at an aggregate $316 million. The Davis Polk team included partners David Bauer, Yasin Keshvargar and Mark Mendez. Latham & Watkins counseled the initial purchasers. The Latham & Watkins team was led by partners Greg Rodgers, Arash Aminian Baghai and Brent Epstein. The notes come due 2029.
Biotech & Pharmaceuticals
August 16, 2024, 12:11 PM